Your browser doesn't support javascript.
loading
Amyloid precursor protein processing in Alzheimer's disease
IJCN-Iranian Journal of Child Neurology. 2012; 6 (1): 1-4
in English | IMEMR | ID: emr-118619
ABSTRACT
Alzheimer's disease [AD] is a progressive neurodegenerative disorder and a leading cause of dementia. The AD is characterized by presence of intraneuronal tangles and extracellular plaques in the brain. The plaques are composed of dense and mostly insoluble deposits of amyloid beta peptide [A beta], formed by sequential cleavage of the Amyloid Precursor Protein [APP], by two pathways amyloidogenic and non-amyloidogenic. Tangles are composed of paired helical fragments, which aggregate to form, microtubular protein tau. Although A beta plaques are established to be the cause of the disease, there exist genetic factors and other pathological identifications in addition to these which are an integral part of the disease. This article gives an overview into the mechanism of APP action, genetic factors and other pathological identifications contributing to Alzheimer's disease formation
Search on Google
Index: IMEMR (Eastern Mediterranean) Language: English Journal: Iran. J. Child Neurol. Year: 2012

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Language: English Journal: Iran. J. Child Neurol. Year: 2012